Optimisation of growth hormone production by muscle cells using plasmid DNA

Journal of Endocrinology

Volumn 165, Issue 2, 2000, Pages 329-336

  MacColl, G S ^a   Novo, F J ^a   Marshall, N J ^a   Waters, M ^b   Goldspink, G ^a   Bouloux, P M G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; MYOSIN LIGHT CHAIN; PLASMID DNA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; COLORIMETRY; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; HORMONE SYNTHESIS; IMMUNOREACTIVITY; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034042333     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650329     Document Type: Article

References (33)

1. Anwer K, Shi M, French MF, Muller SR, Chen W, Liu QS, Proctor BL, Wang JJ, Mumper RJ, Singhal A, Rolland AP & Alila HW 1998 Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine. Human Gene Therapy 9 659-670.
2. Barnhart KM, Hartikka J, Manthorpe M, Norman J & Hobart P 1998 Enhancer and promoter chimeras in plasmids designed for intramuscular injection: a comparative in vivo and in vitro study. Human Gene Therapy 9 2545-2553.
3. Barr E & Leiden JM 1991 Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254 1507-1509.
4. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N & Sweeney HL 1998 Viral mediated expression of insulin-like growth factor-I blocks the aging-related loss of skeletal muscle function. Proceedings of the National Academy of Sciences of the USA 95 15603-15607.
5. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K & Isner JM 1998 Constitutive expression of phVEGF(165) after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 1114-1123.
6. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SG, Miller SC & Webster C 1985 Plasticity of the differentiated state. Science 230 758-766.
7. Cribbs LL, Shimizu N, Yockey CE, Levin JE, Jakovcic S, Zak R & Umeda PK 1989 Muscle-specific regulation of a transfected rabbit myosin heavy chain beta gene promoter. Journal of Biological Chemistry 264 10672-10678.
8. Dahler A, Wade RP, Muscat GEO & Waters MJ 1994 Expression vectors encoding human growth hormone (hGH) controlled by human muscle-specific promoters - prospects for regulated production of hGH delivered by myoblast transfer or intravenous injection. Gene 145 305-310.
9. Donoghue M, Ernst H, Wentworth B, Nadal-Ginard B & Rosenthal N 1988 A muscle-specific enhancer is located at the 3′ end of the myosin light-chain 1/3 gene locus. Genes and Development 2 1779-1790.
10. Draghia-Akli R, Li XY & Schwartz RJ 1998 Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector. Nature Biotechnology 15 1285-1289.
11. Ferrari G, Cusella DeAngelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G & Mavilio F 1998 Muscle regeneration by bone marrow derived myogenic progenitors Science 279 1528-1530.
12. Floyd SS, Booth DK, van Deukekom JCT, Day CS & Huard J 1997 Autologous myoblast transfer: a combination of myoblast transplantation and gene therapy. Basic and Applied Myology 7 241-250.
13. Goodwin CJ, Holt SJ, Downes S & Marshall NJ 1996 The use of intermediate electron-acceptors to enhance MTT bioreduction in a microculture tetrazolium assay for human growth hormone. Life Sciences 59 1745-1753.
14. Gorman CM, Moffat LF & Howard BH 1982 Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Molecular Cell Biology 2 1044-1051.
15. Haase G, Kennel P, Vigne E, Akli S, Revah F, Schmalbruch H & Kahn A 1996 Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nature Medicine 3 429-436.
16. Harlow E & Lane D 1988 Antibodies, A Laboratory Manual. New York: Cold Spring Harbour Laboratory Press.
17. Lehtinen SK, Rahkila P, Helenius M, Korhonen P & Salminen A 1996 Down-regulation of transcription factors AP-1, SP-1, and NF-kappa-B precedes myocyte differentiation. Biochemical and Biophysical Research Communications 229 36-43.
18. Li XY, Eastman EM, Schwartz RJ & Draghia-Akli R 1999 Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences. Nature Biotechnology 17 241-245.
19. MacColl G, Novo J, Marshall N, Goldspink G & Bouloux P 1998 A method for producing biologically active growth hormone in muscle cells. Journal of Endocrinology (Suppl) 156 OC 20.
20. MacColl G, Goldspink G & Bouloux P 1999 Using skeletal muscle as an artificial endocrine tissue. Journal of Endocrinology 162 1-9.
21. Miller G, Steinbrecher RA, Murdock PJ, Tuddenham EGD, Lee CA, Pasi KJ & Goldspink G 1995 Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: modelling gene therapy for haemophilia. Gene Therapy 2 736-742.
22. Murphy JE, Zhou SZ, Giese K, Williams LT, Escobedo JA & Dwarki VJ 1997 Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proceedings of the National Academy of Sciences of the USA 94 13921-13926.
23. Neville C & Rosenthal N 1996 Transcriptional regulation of skeletal myogenesis. In Eukaryotic Gene Transcription, edn 1, pp 192-233. Ed S Goodbourn. Oxford: IRL Press.
24. Novo FJ, Gorecki DC, Goldspink G & MacDermot KD 1997 Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo. Gene Therapy 4 488-492.
25. Rowlinson SW, Waters MJ, Lewis UJ & Barnard R 1996 Human growth-hormone fragments 1-43 and 44-191 - in vivo somatogenic activity and receptor-binding characteristics in human and nonprimate systems. Endocrinology 137 90-95.
26. Sambrook J, Fritsch EF & Maniatis T 1989 Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbour Laboratory Press.
27. Sanger F, Nicklen S & Coulson AR 1977 DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences of the USA 74 5463-5467.
28. Seeburg PH, Shine J, Martial JA, Baxter JD & Goodman HM 1977 Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature 270 486-494.
29. Skarli M, Kiri A, Vrbova G, Lee CA & Goldspink G 1998 Myosin regulatory elements as vectors for gene transfer by intramuscular injection. Gene Therapy 5 514-520.
30. Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, Isner JM & Symes JF 1994 Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of limb ischaemia. Circulation 90 228-243.
31. Tripathy SK, Goldwasser E, Lu MM, Barr E & Leiden JM 1994 Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-deficient adenovirus. Proceedings of the National Academy of Sciences of the USA 91 11557-11561.
32. Tripathy SK, Svensson EC, Black HB, Goldwasser E, Margalith M, Hobart PM & Leiden JM 1996 Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proceedings of the National Academy of Sciences of the USA 93 10876-10880.
33. Trivedi RA & Dickson G 1995 Liposome-mediated gene-transfer into normal and dystrophin-deficient mouse myoblasts. Journal of Neurochemistry 64 2230-2238.